Clinical Trials Logo

Cerebral Angiogenesis clinical trials

View clinical trials related to Cerebral Angiogenesis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01819597 Completed - Ischemic Stroke Clinical Trials

Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis

ERSIAS
Start date: March 2013
Phase: N/A
Study type: Interventional

Stroke due to intracranial arterial atherosclerosis is a significant medical problem, carrying one of the highest rates of recurrent stroke despite best medical therapy, with annual recurrence rates as elevated as 25% in high risk groups. The goal of this investigation is to advance a promising surgical treatment for symptomatic atherosclerotic intracranial stenosis - encephaloduroarteriosynangiosis (EDAS). The investigation will test in a phase II futility trial the potential of EDAS for further development before proceeding with the design of a definitive clinical trial of EDAS Revascularization in patients with Symptomatic Intracranial Arterial Stenosis (ERSIAS). The investigation is a 4-year futility trial to test the hypothesis that EDAS revascularization combined with aggressive medical therapy warrants further evaluation in a subsequent pivotal trial as an alternative to aggressive medical management alone for preventing the primary endpoint of stroke or death in patients with symptomatic intracranial arterial stenosis (Specific Aim 1). During the investigation the time course of collateralogenesis and perfusion improvement following EDAS will also be evaluated (Specific Aim 2.